BCDA
Price
$2.17
Change
+$0.04 (+1.88%)
Updated
Jun 6 closing price
Capitalization
11.03M
CDTX
Price
$25.22
Change
+$1.17 (+4.86%)
Updated
Jun 6 closing price
Capitalization
311.92M
Interact to see
Advertisement

BCDA vs CDTX

Header iconBCDA vs CDTX Comparison
Open Charts BCDA vs CDTXBanner chart's image
BioCardia
Price$2.17
Change+$0.04 (+1.88%)
Volume$13.14K
Capitalization11.03M
Cidara Therapeutics
Price$25.22
Change+$1.17 (+4.86%)
Volume$192.83K
Capitalization311.92M
BCDA vs CDTX Comparison Chart
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. CDTX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Hold and CDTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (BCDA: $2.11 vs. CDTX: $22.69)
Brand notoriety: BCDA and CDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 72% vs. CDTX: 137%
Market capitalization -- BCDA: $11.03M vs. CDTX: $311.92M
BCDA [@Biotechnology] is valued at $11.03M. CDTX’s [@Biotechnology] market capitalization is $311.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileCDTX’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • CDTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 3 TA indicator(s) are bullish while CDTX’s TA Score has 6 bullish TA indicator(s).

  • BCDA’s TA Score: 3 bullish, 7 bearish.
  • CDTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than BCDA.

Price Growth

BCDA (@Biotechnology) experienced а +12.23% price change this week, while CDTX (@Biotechnology) price change was -13.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($312M) has a higher market cap than BCDA($11M). BCDA YTD gains are higher at: -3.211 vs. CDTX (-15.588). BCDA has higher annual earnings (EBITDA): -7.69M vs. CDTX (-175.87M). CDTX has more cash in the bank: 190M vs. BCDA (4.93M). BCDA has less debt than CDTX: BCDA (1.05M) vs CDTX (3.58M). CDTX has higher revenues than BCDA: CDTX (1.28M) vs BCDA (71K).
BCDACDTXBCDA / CDTX
Capitalization11M312M4%
EBITDA-7.69M-175.87M4%
Gain YTD-3.211-15.58821%
P/E RatioN/AN/A-
Revenue71K1.28M6%
Total Cash4.93M190M3%
Total Debt1.05M3.58M29%
FUNDAMENTALS RATINGS
BCDA vs CDTX: Fundamental Ratings
BCDA
CDTX
OUTLOOK RATING
1..100
7571
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6239
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (77) in the Biotechnology industry is in the same range as BCDA (91) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's SMR Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's Price Growth Rating (39) in the Biotechnology industry is in the same range as BCDA (62) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDACDTX
RSI
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
87%
MACD
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
81%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
89%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with RNAC. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.93%
RNAC - BCDA
85%
Closely correlated
+3.65%
CDTX - BCDA
85%
Closely correlated
-5.46%
AGEN - BCDA
85%
Closely correlated
-14.93%
NBY - BCDA
84%
Closely correlated
-0.58%
WINT - BCDA
84%
Closely correlated
+5.12%
More

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-5.46%
WINT - CDTX
94%
Closely correlated
+5.12%
NBY - CDTX
93%
Closely correlated
-0.58%
NCNA - CDTX
93%
Closely correlated
-3.85%
SNPX - CDTX
93%
Closely correlated
-10.74%
BPTSY - CDTX
92%
Closely correlated
N/A
More